Search

Search bills, members, committees and pages...

PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL

5 federal lobbying filings, 2025 to 2026.

PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL is a client on 5 federal lobbying filings, 2025 to 2026, reporting $140K across them. Consulting / Company that specializes in advanced prostate cancer diagnostics. Based in South Carolina.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Firms

1 it has hired, by filings.

RegistrantFilingsReported
W STRATEGIES, LLC5$140K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$80K
20253$60K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues5

Lobbyists

Named on the filings.

LobbyistClientsFilings
DARREN WILLCOX15

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALW STRATEGIES, LLC2026 second_quarter$40KJul 20, 2026
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALW STRATEGIES, LLC2026 first_quarter$40KApr 18, 2026
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALW STRATEGIES, LLC2025 fourth_quarter$40KJan 20, 2026
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALW STRATEGIES, LLC2025 third_quarter$20KOct 20, 2025
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALW STRATEGIES, LLC2025 third_quarterSep 25, 2025